| Cover - USD ($) | 12 Months Ended | ||
| Dec. 31, 2022 | Mar. 28, 2023 | Jun. 30, 2022 | |
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | Bone Biologics Corporation (the “Company,” “we,” “us,” or “our”) is filing this Amendment No. 1 (the “Amendment”) to our Annual Report on Form 10-K for its fiscal year ended December 31, 2022 filed with the Securities and Exchange Commission (the “SEC”) on March 30, 2023 (the “Annual Report”), for the sole purpose of including exhibits that were unintentionally omitted from the Annual Report. | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2022 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2022 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 001-40899 | ||
| Entity Registrant Name | Bone Biologics Corporation | ||
| Entity Central Index Key | 0001419554 | ||
| Entity Tax Identification Number | 42-1743430 | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Address, Address Line One | 2 Burlington Woods Drive | ||
| Entity Address, Address Line Two | Ste 100 | ||
| Entity Address, City or Town | Burlington | ||
| Entity Address, State or Province | MA | ||
| Entity Address, Postal Zip Code | 01803 | ||
| City Area Code | (781) | ||
| Local Phone Number | 552-4452 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 4,403,460 | ||
| Entity Common Stock, Shares Outstanding | 16,702,912 | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Auditor Firm ID | 572 | ||
| Auditor Name | Weinberg & Company, P.A. | ||
| Auditor Location | Los Angeles, California | ||
| Common stock, $0.001 par value per share | |||
| Title of 12(b) Security | Common stock, $0.001 par value per share | ||
| Trading Symbol | BBLG | ||
| Security Exchange Name | NASDAQ | ||
| Warrants to Purchase Common stock, $0.001 par value per share | |||
| Title of 12(b) Security | Warrants to Purchase Common stock, $0.001 par value per share | ||
| Trading Symbol | BBLGW | ||
| Security Exchange Name | NASDAQ |
